Figure 2. Predicted Prevalence of Therapeutic Inertia by Race and Ethnicity in the Standard and Intensive Treatment Arms of the Systolic Blood Pressure Intervention Trial.

Predicted probability of therapeutic inertia is shown for participants randomized to the standard treatment arm (A) and intensive treatment arm (B). This figure represents an average model-based, multivariable-adjusted estimated probability of therapeutic inertia at each participant visit by race and ethnicity averaged across the observed values of all other covariates in the logistic regression model. Prediction values are based on model 3, which is adjusted for race and ethnicity and time in addition to age, sex, education, employment, living with others, insurance status, source of care, smoking status, body mass index, depression, statin use, and aspirin use, as well as most recent visit SBP, eGFR, serum potassium, serum sodium, number of antihypertensive medications, prior mTIS, angiotensin converting enzyme inhibitor/angiotensin converting enzyme inhibitor, calcium channel blocker, thiazide diuretic, loop diuretic, beta-blocker, alpha-blocker, number of nonantihypertensive medications, and serious adverse events reported within 1 month before the study visit..